Previous close | 160.39 |
Open | 161.34 |
Bid | 162.29 x 1800 |
Ask | 162.22 x 1200 |
Day's range | 160.56 - 162.51 |
52-week range | 133.65 - 173.65 |
Volume | 9,034,379 |
Avg. volume | 8,189,491 |
Market cap | 427.131B |
Beta (5Y monthly) | 0.72 |
PE ratio (TTM) | 29.44 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 4.04 (2.52%) |
Ex-dividend date | 22 Feb 2021 |
1y target est | N/A |
Assistant Professor of Emergency Medicine at Baylor College of Medicine, Dr. Sara Andrabi, joined Yahoo Finance to break down her thoughts on the possibility of needing annual COVID-19 booster shots to.
The CEO of Pfizer has warned that a third COVID-19 vaccine dose will likely be necessary within 12 months. Get Us PPE Co-Founder and Harvard Medical School Professor Dr. Ali Raja joins Yahoo Finance Live to discuss.
Pfizer CEO sees need for a third vaccine dose as Moderna updates its timeline on third booster shot. Pause on the Johnson & Johnson vaccine remains. Yahoo Finance’s Anjalee Khemlani breaks down the details.